Tumor-induced osteomalacia originating from the temporal bone: a case report
Related Experiment Video
Updated: Jun 16, 2026
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Kenya Kobayashi1, Kazunari Nakao, Kensuke Kawai
1Department of Otolaryngology, Head and Neck Surgery, Kanto Medical Center NTT EC, Tokyo, Japan. kenyajp@hotmail.com
Background:
Tumor-induced osteomalacia (TIO) is a rare clinical entity in which secondary osteomalacia is induced by tumor-related products. Fibroblast growth factor 23 (FGF-23) mRNA is overexpressed in the tumor tissue, leading to impaired reabsorption of phosphorus in the renal tubules and hypophosphatemia. Curative treatment is considered to be total resection of the tumor.
Methods And Results:
A 53-year-old woman had experienced systemic bone pain and muscle weakness for several years. She had refractory hypophosphatemia and marked elevation of serum FGF-23 level. Whole body imaging eventually revealed a hypervascular mass in the right temporal bone, leading to a diagnosis of TIO. She underwent skull-base surgery after embolization of the tumor. After the en bloc resection, FGF-23 became undetectable, phosphate reabsorption normalized, and all symptoms resolved.
Conclusions:
We discuss the clinical features and treatment options for this rare disease.
